University Hospital Antwerp
🇧🇪Belgium
Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)
Not Applicable
Recruiting
- Conditions
- Body Weight ChangesFluid and Electrolyte ImbalanceChildren, Only
- Interventions
- Diagnostic Test: bio impedance spectroscopy by means of the Body Composition Monitor (Name of the device is BCM from Fresenius Medical Care D GmbH)
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 100
- Registration Number
- NCT05220709
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Antwerp, Belgium
Hear Again, Work Again
Recruiting
- Conditions
- Hearing Loss, UnilateralHearing Loss, Sensorineural, SevereHearing Loss, Sensorineural, BilateralHearing Loss, Sensorineural, ProfoundCochlear Implants
- Interventions
- Other: Cochlear implant
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 200
- Registration Number
- NCT05196022
- Locations
- 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium
Biodistribution and Dosimetry of 99mTc-Duramycin
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 6
- Registration Number
- NCT05177640
- Locations
- 🇧🇪
University Hospital Antwerp, Edegem, Antwerpen, Belgium
cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes
Completed
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2021-10-28
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 21
- Registration Number
- NCT05097339
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Antwerp, Belgium
Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 60
- Registration Number
- NCT05095064
- Locations
- 🇧🇪
Antwerp University Hosptital, Edegem, Belgium
Plastic Surgery Training in Europe
Completed
- Conditions
- Plastic Surgery Training
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 20
- Registration Number
- NCT05070806
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Belgium
The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Other: Blood sampling
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 402
- Registration Number
- NCT05033158
- Locations
- 🇧🇪
AZ Groeninge, Kortrijk, Belgium
🇧🇪AZ Nikolaas, Sint-Niklaas, Belgium
🇧🇪University Hospital Antwerp, Edegem, Antwerp, Belgium
Combined PENG and LFCN Block for Total Hip Arthroplasty
Not Applicable
Completed
- Conditions
- Anesthesia, ConductionPain, PostoperativeArthroplasty, Replacement, Hip
- Interventions
- Procedure: PENG + LFCN block
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 40
- Registration Number
- NCT04996290
- Locations
- 🇧🇪
AZ Monica, Deurne, Belgium
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy
Not Applicable
Not yet recruiting
- Conditions
- Amyloid PolyneuropathyCardiomyopathy Non-DilatedHeart FailureAmyloidosis CardiacAmyloidosisCardiomyopathies, Secondary
- Interventions
- Diagnostic Test: Specific diagnostic work-up for ATTR-CM patients
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 200
- Registration Number
- NCT04985734
- Locations
- 🇧🇪
Emeline van Craenenbroek, Edegem, Antwerp, Belgium
Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma
Phase 1
Active, not recruiting
- Conditions
- Diffuse Intrinsic Pontine GliomaHigh Grade Glioma
- Interventions
- Biological: Dendritic cell vaccination + temozolomide-based chemoradiationBiological: Dendritic cell vaccination +- conventional next-line treatment
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 10
- Registration Number
- NCT04911621
- Locations
- 🇧🇪
Unitversity Hospital Antwerp, Edegem, Belgium
© Copyright 2025. All Rights Reserved by MedPath